clock menu more-arrow no yes mobile

Filed under:

Peter Thiel's Breakout Labs Funds Trio of Health Startups

Breakout Labs, investor Peter Thiel’s nonprofit fund for science startups, has provided $350,000 grants to three early-stage health companies. The recipients include: Cortexyme, which is focused on treatments for Alzheimer’s and other neurological disorders; G-Tech Medical, which is developing an “EKG for the gut” to determine the root cause of gastrointestinal disorders; and EpiBone, which is attempting to use stem cells to create “patient-specific bone tissue replacement.” Breakout Labs generally awards grants from $50,000 to $350,000. The companies, in turn, provide a “modest royalty stream” used to fund additional startups.

This article originally appeared on

Sign up for the newsletter Sign up for Vox Recommends

Get curated picks of the best Vox journalism to read, watch, and listen to every week, from our editors.